Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mushfiq Akanda"'
Publikováno v:
Drug delivery and translational research.
Nanostructure lipid carriers (NLCs) were developed for the delivery of curmumin (CRN), a potent anticancer agent with low bioavailability, for the treatment of prostate cancer. NLCs prepared using high pressure homogenization (HPH) with around 150 nm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::333bfa9c4065f6906d6c19018eee78fb
https://pubmed.ncbi.nlm.nih.gov/34845679
https://pubmed.ncbi.nlm.nih.gov/34845679
Prostate cancer is one of the prominent causes of cancer mortality in men all over the world and a challenge to treat. In this study, transferrin (Tf) bioconjugated solid lipid nanoparticles (SLNs) were developed and loaded with curcumin (CRC) for ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35b6eb3eeaa1496a8968be13079a6818
http://gala.gre.ac.uk/id/eprint/36007/3/36007_DOUROUMIS_Bioconjugated_solid_lipid.pdf
http://gala.gre.ac.uk/id/eprint/36007/3/36007_DOUROUMIS_Bioconjugated_solid_lipid.pdf
Autor:
Babur Z. Chowdhry, Ian J. Slipper, Rajeev Rai, Giulia Getti, Dimitrios A. Lamprou, Mushfiq Akanda, Dennis Douroumis
Publikováno v:
International journal of pharmaceutics. 493(1-2)
In this study retinoic acid (RTA) loaded solid lipid nanoparticles (SLNs) were optimized by tuning the process parameters (pressure/temperature) and using different lipids to develop nanodispersions with enhanced anticancer activity. The RTA-SLN disp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f53852fbb54ce06862caae398fd4236d
https://pubmed.ncbi.nlm.nih.gov/26200751
https://pubmed.ncbi.nlm.nih.gov/26200751